Abasi has worked in the US, UK and Nigerian healthcare space. He was previously a management consultant working with PwC and IQVIA (formerly QuintilesIMS) and has consulted for/ worked with leading healthcare organisations including fortune 100 pharmaceutical companies, academic and research institutions and governments. Abasi has also worked as a cancer researcher and published a seminal paper on pancreatic cancer immunology in the journal, Gastroenterology. He holds a PhD in Cancer Biology from University of London, a masters in human molecular genetics from the Imperial College London and a masters in business management from the Claremont Colleges, California.

Dami was the Managing Partner at Medismarts International, a Health Technology Company he co-founded in 2015 which is at the forefront of providing technology to the health industry in Nigeria. He led Medismart to deploy their cloud EMR platform in 140 hospitals and to gain 36% market share of claims processed in Nigeria. Damilola also led the team that carried out process reengineering for 20 departments of the government of Kaduna State, and has also worked on projects for Deloitte and Pharmaccess. Dami holds a B.sc degree in Economics from the Obafemi Awolowo University and is passionate about ensuring that the healthcare industry in Africa is technology driven.

Dr. Omolola Salako is a consultant clinical and radiation oncologist with a special interest in breast, head and neck cancer and economics of cancer. She is an active cancer researcher and cancer advocate. Dr Salako’s research interests include breast cancer radiotherapy techniques, novel risk factors in women of African descent and radiation toxicities. In addition to her clinical responsibilities, Dr Salako is a patient advocate with extensive skills in counselling, advocacy and survivorship.
She earned her MBBS degree at College of Medicine, University of Lagos, completed horsemanship and a residency in Radiation Oncology at Lagos University Teaching Hospital in 2006 and 2013 respectively.

Gatumi is a global health-tech professional with over 7 years experience leading, managing and working with teams in healthcare, business, technology and investment banking. Prior to co-founding Stack Diagnostics, he worked in global institutions like Shell, Renaissance Capital and most recently as the Head of Operations in a tech accelerator.

Francis has over 10 years software development experience building enterprise solutions for businesses across Nigeria. He has also led teams to build solutions for Visa, DFID, Microsoft, and more. The products he has built have gotten local and international recognition for innovation and performance. He is an alumni of Fate Foundation and Lagos Business School.

Jumoke Popoola is a multi-disciplinary cancer research scientist that has worked at The Institute of Cancer Research and The Royal Marsden Cancer Hospital in London, in collaboration with Merck KGaA, Germany. She designed and implemented high throughput screening assays, which enabled fast tracking of drugs into clinical trials for patient benefit. She is highly skilled in the miniaturization and optimisation of diagnostics and research software, research equipment and assays to enable more accurate and faster dissemination of data relevant for precision personalised medicine and timely development of clinical candidate drugs. She is a member of the British Association for Cancer Research (BACR) as well as the American Association for Cancer Research (AACR) and regularly presents research publications at conferences nationally and internationally. She has also worked in Chevron and has worked with Boehringer Ingelheim GmbH, to launch the drug Prostatonin into the Nigerian market, for the treatment of enlarged prostate (BPH). She is an active participant in the global drug discovery community.